Proteinuria and hypertensive nephrosclerosis in African Americans

Kidney International, Supplement

Volumn 66, Issue 92, 2004, Pages

  Toto, Robert D ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

African American; Albuminuria; Cardiovascular death; Chronic kidney disease; Proteinuria

Indexed keywords

AMLODIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METOPROLOL; RAMIPRIL;

AFRICAN AMERICAN; ALBUMINURIA; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; FOLLOW UP; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; MULTICENTER STUDY; NEPHROSCLEROSIS; OUTCOMES RESEARCH; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; ETHNOLOGY; RENOVASCULAR HYPERTENSION; REVIEW; RISK FACTOR;

AFRICAN AMERICANS; HUMANS; HYPERTENSION, RENAL; NEPHROSCLEROSIS; PROTEINURIA; RISK FACTORS;

EID: 16644394042     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.09224.x     Document Type: Article

References (14)

1. JONES CA, FRANCIS M, EBERHARDT MS, et al: Microalbuminuria in the US Population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 39:445-459, 2002
2. MATIX H, HSU CY, KEVICH SS, CURHAN GC: Use of the albumin/creatinine ratio to detect microalbuminuria: Implications of sex and race. J Am Soc Nephrol 13:1034-1039, 2002
3. DINNEEN SF, GERSTEIN HC: The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med 157:1413-1418, 1997
4. HSU CY, LIN F, VITTINGHOFF E, SHLIPAK MG: Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol 14:2902-2907, 2003
5. POLLAK MR: The genetic basis of FSGS and steroid-resistant nephrosis. Semin Nephrol 23:141-146, 2003
6. CAMERON JS: Focal segmental glomerulosclerosis in adults. Nephrol Dial Transplant 18(Suppl 6):vi45-51, 2003
7. D'AGATI VD, FOGO AB, BRUIJN JA, JENNETTE JC: Pathologic classification of focal segmental glomerulosclerosis: A working proposal. Am J Kidney Dis 43:368-382, 2004
8. MARCATONI M, MA L, FEDERSPIEL C, FOGO A: Hypertensive nephrosclerosis in African-Americans and Caucasians. Kidney Int 62:172-180, 2002
9. PERRY HM, JR., MILLER JP, FORNOFF JR, et al: Early predictors of 15-year end-stage renal disease in hypertensive patients. Hypertension 25:587-594, 1995
10. WRIGHT JT, JR., KUSEK JW, TOTO RD, et al: Design and baseline characteristics of participants in the African-American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Control Clin Trials 17(4 Suppl):3S-16S, 1996
11. USRDS 2003 ANNUAL DATA REPORT: Atlas of End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2003
12. AGODOA LY, APPEL L, BAKRIS GL, et al: African American Study of Kidney Disease and Hypertension (AASK) Study Group Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: A randomized controlled trial. JAMA 285:2719-2728, 2001
13. WRIGHT JT, JR., BAKRIS G, GREENE T, et al: African American Study of Kidney Disease and Hypertension Study Group Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial. JAMA 288:2421-2431, 2002
14. APPEL LJ, MIDDLETON J, MILLER ER III, et al: The rationale and design of the AASK Cohort Study. J Am Soc Nephrol 14(Suppl 2):S166-172, 2003